On June 18th, Dr. Zhou Zeqi led the Dynamier team to visit the Institute for Medical Research in Malaysia, a century-old research hub. He delivered a keynote speech titled "Innovation Drives Precision Diagnosis of IFD" at the national biomedical center, founded in 1900.
At the Kuala Lumpur General Hospital's laboratory, Dr. Zhou Zeqi and a team of experts focused on Aspergillus diagnostic strategies and rapid Cryptococcal testing solutions. Targeting different clinical scenarios, enzyme-linked immunosorbent assays (ELISAs) offer high accuracy for critical diagnosis, molecular testing offers strong discrimination for complex cases, and point-of-care (POCT) technology empowers grassroots screening with rapid response, building a multi-layered defense system against Aspergillus. Dynamiker Cryptococcal colloidal gold test received high praise from the laboratory director: "It maintains excellent stability and efficiency in high-temperature and high-humidity environments. This is the hardcore solution urgently needed in tropical regions!" Riding the wave of innovation and working together to expand globally, 5G+ panel testing is making a splash!
From laboratories in Bohai Bay to bedside care in Malacca, Dynamiker is expanding its 5G+ panel testing suite to Malaysia, building a defense line against IFD in Southeast Asia.